Lucentis (ranibizumab): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Lucentis 10 mg/ml solution for injection

Lucentis is indicated in adults for:

• The treatment of neovascular (wet) age-related macular degeneration (AMD)

• The treatment of visual impairment due to choroidal neovascularisation (CNV)

• The treatment of visual impairment due to diabetic macular oedema (DME)

• The treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO)

Lucentis 10 mg/ml solution for injection in pre-filled syringe

Lucentis is indicated in adults for:

• The treatment of neovascular (wet) age-related macular degeneration (AMD)

• The treatment of visual impairment due to choroidal neovascularisation (CNV)

• The treatment of visual impairment due to diabetic macular oedema (DME)

• The treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO)


Route of administration: Injectable
Molecule: ranibizumab

Patients' opinions on Lucentis

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.